Intervention

Hydrogen Water

Hydrogen-Rich Water (Molecular Hydrogen Supplementation)

Water infused with dissolved molecular hydrogen (H2), consumed via electrolysis bottles, tablets, or pre-packaged bottles, proposed to reduce oxidative stress and inflammation through selective antioxidant mechanisms.

Editor approved Evidence: Tier 3

Research snapshot FDA GRAS (Generally Recognized As Safe) for dissolved hydrogen in beverages up to 2.14% by volume. No medical device approvals. Sold as consumer wellness products. FDA warning letter issued to one company for disease-treatment claims (2022).

Updated 2026-08-13

Hydrogen water has more human clinical data than many longevity interventions, with 81 registered trials and multiple meta-analyses. The 6-month aging biomarker trial (telomere length, TET2 expression, physical function) is the most longevity-relevant finding, but it is a pilot trial (N=40) from a single research group. Meta-analyses show statistically significant but clinically modest effects on lipids and exercise performance. No large RCTs with hard endpoints exist. Evidence tier 3 reflects multiple human RCTs and meta-analyses with surrogate endpoints, but no large-scale confirmation. Safety profile is strong across all published studies.

Latest finding

A 6-month RCT (N=40, adults aged 70+) found hydrogen-rich water preserved telomere length while controls showed telomere shortening (p=0.049), and increased TET2 expression (p=0.040), an epigenetic regulator linked to aging. A 2026 meta-analysis of 13 RCTs (n=757) found small but statistically significant reductions in total cholesterol (-6.71 mg/dL, p<0.001) and LDL-C (-3.21 mg/dL, p=0.043), though authors concluded the effects were below clinically meaningful thresholds. A 2024 meta-analysis of 27 studies (n=597) found improved explosive power and reduced perceived exertion during exercise, but no effect on aerobic endurance or muscular strength.

0.5-1.6 ppm

H2 concentration in water

0.5-1.0 L/day

Daily intake in RCTs

6 months

Longest RCT duration

40 (aging biomarkers)

Largest RCT N

81 (ClinicalTrials.gov + UMIN)

Total clinical trials registered

-6.71 mg/dL (13 RCTs, n=757)

Meta-analysis: TC reduction

0.30, p=0.018 (27 studies)

Meta-analysis: explosive power SMD

p=0.049 (N=40, 6 months)

Aging RCT: telomere length

Safety

No severe adverse effects reported across all published human trials. FDA GRAS status since 2014. No known drug interactions. Safety confirmed in elderly (70+), obese, NAFLD, and athlete populations. Quality and actual H2 concentration vary between consumer devices. Some electrolysis devices may produce unwanted byproducts if source water quality is poor.

What is next

Large-scale RCTs (N>500) with hard longevity endpoints (mortality, cardiovascular events, cognitive decline) are needed. Current evidence is limited to pilot-sized trials with surrogate biomarkers. The telomere length finding in older adults warrants replication in larger cohorts. Optimal dosing, delivery method (bottle vs tablet vs pre-packaged), and treatment duration remain undefined.

References

Evidence tierTier 3, Mixed human evidence, mechanism plausible

Typical dose0.5-1.0 L per day of hydrogen-rich water containing 0.5-1.6 ppm dissolved H2 (approximately 0.5-15 mg H2 total). Delivered via: (1) electrolysis bottles/flasks that generate H2 in situ, (2) magnesium-based effervescent tablets dissolved in water (producing ~1.6 ppm H2), (3) pre-packaged hydrogen-infused bottles. Intake duration in RCTs ranged from single doses to 6 months continuous use.

SafetyFDA GRAS status for dissolved hydrogen in beverages. No severe adverse effects reported in any published human trial as of 2026. No known drug interactions. Hydrogen gas is non-toxic, non-carcinogenic, and chemically inert at physiological concentrations. Theoretical concerns: H2 gas is flammable at 4-75% concentration in air, but dissolved concentrations in water are far below any flammability risk. Quality and actual H2 concentration vary widely between consumer devices and brands. Some electrolysis devices may produce byproducts (ozone, chlorine) if water quality is poor.

Categoryhydration therapy

Last verified2026-08-13

What it is

Hydrogen-rich water (HRW) is regular drinking water infused with dissolved molecular hydrogen gas (H2). The hydrogen acts as a potential therapeutic agent — not the water itself. Three delivery methods dominate the market: (1) electrolysis bottles and flasks that generate H2 in situ via electrolysis of water, (2) magnesium-based effervescent tablets that react with water to produce H2 gas, and (3) pre-packaged aluminum bottles or cans of hydrogen-infused water. Typical dissolved concentrations range from 0.5 to 1.6 ppm.

How it works

Molecular hydrogen is the smallest molecule known, allowing rapid diffusion across cell membranes, into mitochondria, and across the blood-brain barrier. Proposed mechanisms include:

- Selective antioxidant action: H2 scavenges hydroxyl radicals (OH-) and peroxynitrite (ONOO-) — the most cytotoxic reactive oxygen species — without neutralizing beneficial signaling ROS like hydrogen peroxide or superoxide. This selectivity distinguishes H2 from broad-spectrum antioxidants like vitamin E or vitamin C. - Nrf2 pathway activation: H2 upregulates the Nrf2/Keap1 transcription factor, which activates endogenous antioxidant defense enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase. - Anti-inflammatory signaling: H2 suppresses NF-kB-mediated inflammatory cascades, reducing pro-inflammatory cytokines including TNF-alpha and IL-6. - Epigenetic effects: A 6-month trial in adults aged 70+ found increased TET2 expression (p=0.040), an epigenetic regulator involved in DNA demethylation and linked to aging hallmarks. - Mitochondrial bioenergetics: H2 may improve mitochondrial function by reducing oxidative damage to mitochondrial DNA and membranes.

Evidence

Aging biomarkers (most relevant to longevity) A 6-month randomized controlled pilot trial (Zanini et al., 2021) in 40 adults aged 70+ found: - Telomere length preserved in HRW group vs shortening in controls (p=0.049) - TET2 expression increased significantly more in HRW group (p=0.040) - Chair stand performance improved (p=0.01) - Brain metabolites (NAA, choline, creatine) increased in specific regions - NCT04430803, published in Experimental Gerontology

This is the most longevity-relevant human trial, but it is pilot-sized (N=40) and from a single research group (University of Novi Sad, Serbia). Replication is needed.

Metabolic health - NAFLD RCT (N=12, crossover, 28 days): liver fat reduced by 2.9% (95% CI: 0.5 to 5.5), AST reduced 10%. NCT03625362. - HYDRAPPET RCT (N=36, 8 weeks): reduced cravings (p=0.05), improved sleep quality (p=0.05), reduced total cholesterol (p=0.02) and LDL (p=0.04), increased GLP-1 (p=0.05). No severe adverse effects. NCT06722326. - 2026 lipid meta-analysis (13 RCTs, n=757): TC reduced -6.71 mg/dL (p<0.001), LDL-C reduced -3.21 mg/dL (p=0.043). Authors concluded effects were "below clinically meaningful thresholds."

Exercise performance - 2024 meta-analysis (27 publications, 597 participants): improved lower limb explosive power (SMD=0.30, p=0.018), reduced perceived exertion (SMD=-0.37, p=0.009), reduced blood lactate (SMD=-0.37, p=0.001). No effect on aerobic endurance, anaerobic endurance, or muscular strength.

Safety - 2023 comprehensive review identified 81 registered clinical trials and 64 human publications. All trials confirmed safety of H2 consumption. No severe adverse effects reported.

Regulatory - FDA GRAS Notice #520 (2014): hydrogen gas in beverages up to 2.14% by volume is Generally Recognized As Safe. FDA stated no questions. - FDA warning letter to H2 Beverages Inc. (2022) for disease-treatment claims including COVID-19 — not a safety issue, but a marketing enforcement action. - Philippine FDA public health warning against unregistered HW Hydrogenated Water (2024).

What to know

The evidence base for hydrogen water is broader than most longevity interventions — 81 registered trials is substantial. However, nearly all are small (N=10-40), short-duration (days to 6 months), and from a limited number of research groups, primarily in Serbia, Japan, and China. The telomere length finding in older adults is intriguing and directly relevant to aging, but requires replication in larger cohorts. The lipid-lowering effect is real but clinically modest — the 2026 meta-analysis authors explicitly stated it should not justify routine use as a lipid-lowering therapy.

Consumer device quality varies enormously. Some electrolysis bottles may not achieve the H2 concentrations used in clinical trials, and some may produce unwanted byproducts (ozone, chlorine) if source water contains contaminants. Magnesium-based tablets provide more consistent dosing (typically ~1.6 ppm) and were used in the NCT04175301 brain cancer supportive care trial at Stony Brook University.

Bryan Johnson's water filtration system includes an optional module generating 1.6 ppm H2, matching the concentration used in several clinical trials.

Practical considerations

- Electrolysis bottles: $30-300. Quality varies. Look for devices that specify dissolved H2 concentration in ppm, not just ORP (oxidation-reduction potential) which is an indirect and less reliable measure. - Magnesium tablets: $20-60/month. More consistent dosing. Dissolve in water before drinking. Used in multiple clinical trials. - Pre-packaged bottles: $3-6 each. H2 dissipates quickly once opened — consume immediately. - No standard dosing protocol exists. RCTs used 0.5-1.0 L/day at 0.5-1.6 ppm for periods ranging from single doses to 6 months. - Not a replacement for any medical treatment. The FDA has not approved hydrogen water for any disease condition.